CD8-Positive T-Lymphocytes
"CD8-Positive T-Lymphocytes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes.
| Descriptor ID |
D018414
|
| MeSH Number(s) |
A11.118.637.555.567.569.220 A15.145.229.637.555.567.569.220 A15.382.490.555.567.569.220
|
| Concept/Terms |
CD8-Positive T-Lymphocytes- CD8-Positive T-Lymphocytes
- CD8 Positive T Lymphocytes
- CD8-Positive T-Lymphocyte
- T-Lymphocyte, CD8-Positive
- T-Lymphocytes, CD8-Positive
- T8 Lymphocytes
- Lymphocyte, T8
- Lymphocytes, T8
- T8 Lymphocyte
- T8 Cells
- Cell, T8
- Cells, T8
- T8 Cell
- CD8-Positive Lymphocytes
- CD8 Positive Lymphocytes
- CD8-Positive Lymphocyte
- Lymphocyte, CD8-Positive
- Lymphocytes, CD8-Positive
Suppressor T-Lymphocytes, CD8-Positive- Suppressor T-Lymphocytes, CD8-Positive
- CD8-Positive Suppressor T-Lymphocyte
- CD8-Positive Suppressor T-Lymphocytes
- Suppressor T Lymphocytes, CD8 Positive
- Suppressor T-Lymphocyte, CD8-Positive
- T-Lymphocyte, CD8-Positive Suppressor
- T-Lymphocytes, CD8-Positive Suppressor
- Suppressor T-Cells, CD8-Positive
- CD8-Positive Suppressor T-Cell
- CD8-Positive Suppressor T-Cells
- Suppressor T Cells, CD8 Positive
- Suppressor T-Cell, CD8-Positive
- T-Cell, CD8-Positive Suppressor
- T-Cells, CD8-Positive Suppressor
|
Below are MeSH descriptors whose meaning is more general than "CD8-Positive T-Lymphocytes".
Below are MeSH descriptors whose meaning is more specific than "CD8-Positive T-Lymphocytes".
This graph shows the total number of publications written about "CD8-Positive T-Lymphocytes" by people in this website by year, and whether "CD8-Positive T-Lymphocytes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 3 | 3 |
| 1997 | 1 | 1 | 2 |
| 1998 | 1 | 1 | 2 |
| 1999 | 1 | 1 | 2 |
| 2000 | 1 | 2 | 3 |
| 2001 | 3 | 2 | 5 |
| 2002 | 1 | 2 | 3 |
| 2003 | 1 | 5 | 6 |
| 2004 | 7 | 3 | 10 |
| 2005 | 3 | 2 | 5 |
| 2006 | 6 | 3 | 9 |
| 2007 | 5 | 5 | 10 |
| 2008 | 5 | 7 | 12 |
| 2009 | 11 | 4 | 15 |
| 2010 | 3 | 8 | 11 |
| 2011 | 2 | 4 | 6 |
| 2012 | 3 | 5 | 8 |
| 2013 | 8 | 3 | 11 |
| 2014 | 7 | 5 | 12 |
| 2015 | 6 | 4 | 10 |
| 2016 | 3 | 4 | 7 |
| 2017 | 6 | 5 | 11 |
| 2018 | 5 | 7 | 12 |
| 2019 | 12 | 11 | 23 |
| 2020 | 7 | 14 | 21 |
| 2021 | 15 | 11 | 26 |
| 2022 | 5 | 20 | 25 |
| 2023 | 4 | 7 | 11 |
| 2024 | 11 | 11 | 22 |
| 2025 | 3 | 6 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "CD8-Positive T-Lymphocytes" by people in Profiles.
-
Zeaxanthin augments CD8+ effector T cell function and immunotherapy efficacy. Cell Rep Med. 2025 Sep 16; 6(9):102324.
-
Divergent Roles of C/EBP? Isoforms LAP and LIP in Shaping T Cell Dysfunction and Tumor Progression in Triple-Negative Breast Cancer. FASEB J. 2025 Aug 31; 39(16):e70984.
-
Cell type-specific purifying selection of synonymous mitochondrial DNA variation. Proc Natl Acad Sci U S A. 2025 Jul 29; 122(30):e2505704122.
-
Marburg virus glycoprotein mRNA vaccine is more protective than a virus-like particle-forming mRNA vaccine. J Clin Invest. 2025 Sep 02; 135(17).
-
Barcoded viral tracing identifies immunosuppressive astrocyte-glioma interactions. Nature. 2025 Aug; 644(8078):1097-1106.
-
Anti-viral CD8 central memory veto cells as a new platform for CAR T cell therapy. Stem Cells Transl Med. 2025 May 31; 14(6).
-
IL-2-independent expansion, persistence, and antitumor activity in TIL expressing regulatable membrane-bound IL-15. Mol Ther. 2025 Aug 06; 33(8):3605-3623.
-
High tumor CD161 expression predicts a survival advantage and marks a Th1-skewed microenvironment. Front Immunol. 2025; 16:1522755.
-
Lipid nanoparticles deliver DNA-encoded biologics and induce potent protective immunity. Mol Cancer. 2025 Jan 13; 24(1):12.
-
Virus Protein-Specific Immune Responses in Selective Depletion of Lymphocyte Populations Using Monoclonal Antibodies in Bolivian Squirrel Monkeys (Saimiri boliviensis boliviensisv). Viral Immunol. 2025 Jan-Feb; 38(1):12-22.